vs

Side-by-side financial comparison of Neuronetics, Inc. (STIM) and TEJON RANCH CO (TRC). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $21.1M, roughly 2.0× TEJON RANCH CO). TEJON RANCH CO runs the higher net margin — 7.5% vs -17.2%, a 24.7% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 17.7%). Over the past eight quarters, TEJON RANCH CO's revenue compounded faster (68.8% CAGR vs 54.9%).

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

Tejon Ranch Company, based in Lebec, California, is one of the largest private landowners in California. The company was incorporated in 1936 to organize the ownership of a large tract of land that was consolidated from four Mexican land grants acquired in the 1850s and 1860s by ranch founder Edward Fitzgerald Beale.

STIM vs TRC — Head-to-Head

Bigger by revenue
STIM
STIM
2.0× larger
STIM
$41.8M
$21.1M
TRC
Growing faster (revenue YoY)
STIM
STIM
+68.1% gap
STIM
85.7%
17.7%
TRC
Higher net margin
TRC
TRC
24.7% more per $
TRC
7.5%
-17.2%
STIM
Faster 2-yr revenue CAGR
TRC
TRC
Annualised
TRC
68.8%
54.9%
STIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STIM
STIM
TRC
TRC
Revenue
$41.8M
$21.1M
Net Profit
$-7.2M
$1.6M
Gross Margin
52.0%
30.6%
Operating Margin
-12.1%
10.9%
Net Margin
-17.2%
7.5%
Revenue YoY
85.7%
17.7%
Net Profit YoY
43.2%
-64.7%
EPS (diluted)
$-0.10
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STIM
STIM
TRC
TRC
Q4 25
$41.8M
$21.1M
Q3 25
$37.3M
$12.0M
Q2 25
$38.1M
$8.3M
Q1 25
$32.0M
$8.2M
Q4 24
$22.5M
$17.9M
Q3 24
$18.5M
$10.9M
Q2 24
$16.4M
$5.7M
Q1 24
$17.4M
$7.4M
Net Profit
STIM
STIM
TRC
TRC
Q4 25
$-7.2M
$1.6M
Q3 25
$-9.0M
$1.7M
Q2 25
$-10.1M
$-1.7M
Q1 25
$-12.7M
$-1.5M
Q4 24
$-12.7M
$4.5M
Q3 24
$-13.3M
$-1.8M
Q2 24
$-9.8M
$957.0K
Q1 24
$-7.9M
$-914.0K
Gross Margin
STIM
STIM
TRC
TRC
Q4 25
52.0%
30.6%
Q3 25
45.9%
28.4%
Q2 25
46.6%
40.9%
Q1 25
49.2%
15.0%
Q4 24
66.2%
42.9%
Q3 24
75.6%
22.9%
Q2 24
74.0%
45.3%
Q1 24
75.1%
0.3%
Operating Margin
STIM
STIM
TRC
TRC
Q4 25
-12.1%
10.9%
Q3 25
-19.6%
-16.9%
Q2 25
-21.1%
-48.8%
Q1 25
-34.4%
-50.7%
Q4 24
-51.0%
11.9%
Q3 24
-41.7%
-34.9%
Q2 24
-51.7%
-62.4%
Q1 24
-39.4%
-53.8%
Net Margin
STIM
STIM
TRC
TRC
Q4 25
-17.2%
7.5%
Q3 25
-24.3%
14.0%
Q2 25
-26.6%
-20.6%
Q1 25
-39.6%
-17.8%
Q4 24
-56.4%
25.0%
Q3 24
-72.0%
-16.9%
Q2 24
-59.8%
16.8%
Q1 24
-45.2%
-12.3%
EPS (diluted)
STIM
STIM
TRC
TRC
Q4 25
$-0.10
$0.05
Q3 25
$-0.13
$0.06
Q2 25
$-0.15
$-0.06
Q1 25
$-0.21
$-0.05
Q4 24
$-0.34
$0.16
Q3 24
$-0.44
$-0.07
Q2 24
$-0.33
$0.04
Q1 24
$-0.27
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STIM
STIM
TRC
TRC
Cash + ST InvestmentsLiquidity on hand
$28.1M
$9.5M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$22.4M
$475.2M
Total Assets
$141.6M
$630.5M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STIM
STIM
TRC
TRC
Q4 25
$28.1M
$9.5M
Q3 25
$28.0M
$3.6M
Q2 25
$11.0M
$2.5M
Q1 25
$20.2M
$12.3M
Q4 24
$18.5M
$39.3M
Q3 24
$20.9M
$27.4M
Q2 24
$42.6M
$33.0M
Q1 24
$47.7M
$35.6M
Total Debt
STIM
STIM
TRC
TRC
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
STIM
STIM
TRC
TRC
Q4 25
$22.4M
$475.2M
Q3 25
$27.4M
$473.2M
Q2 25
$27.1M
$471.5M
Q1 25
$35.5M
$472.5M
Q4 24
$27.7M
$473.6M
Q3 24
$9.4M
$468.3M
Q2 24
$19.4M
$469.2M
Q1 24
$27.7M
$467.4M
Total Assets
STIM
STIM
TRC
TRC
Q4 25
$141.6M
$630.5M
Q3 25
$145.5M
$629.6M
Q2 25
$134.7M
$618.5M
Q1 25
$142.0M
$614.6M
Q4 24
$140.9M
$608.0M
Q3 24
$598.0M
Q2 24
$96.8M
$590.8M
Q1 24
$103.8M
$581.6M
Debt / Equity
STIM
STIM
TRC
TRC
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STIM
STIM
TRC
TRC
Operating Cash FlowLast quarter
$908.0K
$6.1M
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
3.88×
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STIM
STIM
TRC
TRC
Q4 25
$908.0K
$6.1M
Q3 25
$-785.0K
$-2.4M
Q2 25
$-3.5M
$-381.0K
Q1 25
$-17.0M
$-1.3M
Q4 24
$-8.6M
$14.3M
Q3 24
$-5.4M
$2.1M
Q2 24
$-5.0M
$-1.8M
Q1 24
$-12.0M
$777.0K
Free Cash Flow
STIM
STIM
TRC
TRC
Q4 25
$692.0K
Q3 25
$-899.0K
$-14.6M
Q2 25
$-3.8M
$-20.0M
Q1 25
$-17.2M
$-18.9M
Q4 24
$-8.7M
$-42.9M
Q3 24
$-5.8M
$-16.8M
Q2 24
$-5.6M
$-15.8M
Q1 24
$-12.4M
$-7.3M
FCF Margin
STIM
STIM
TRC
TRC
Q4 25
1.7%
Q3 25
-2.4%
-122.2%
Q2 25
-9.9%
-240.6%
Q1 25
-53.8%
-230.1%
Q4 24
-38.6%
-239.3%
Q3 24
-31.3%
-155.2%
Q2 24
-34.0%
-277.2%
Q1 24
-71.1%
-99.0%
Capex Intensity
STIM
STIM
TRC
TRC
Q4 25
0.5%
Q3 25
0.3%
102.3%
Q2 25
0.7%
236.0%
Q1 25
0.7%
213.7%
Q4 24
0.4%
319.1%
Q3 24
2.1%
174.3%
Q2 24
3.7%
245.5%
Q1 24
2.2%
109.5%
Cash Conversion
STIM
STIM
TRC
TRC
Q4 25
3.88×
Q3 25
-1.43×
Q2 25
Q1 25
Q4 24
3.19×
Q3 24
Q2 24
-1.88×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons